Home/Filings/4/0001104659-22-033496
4//SEC Filing

Kern Ralph Dr. 4

Accession 0001104659-22-033496

CIK 0001137883other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 8:00 PM ET

Size

5.4 KB

Accession

0001104659-22-033496

Insider Transaction Report

Form 4
Period: 2022-03-06
Kern Ralph Dr.
COO and Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-03-06+35,885223,310 total
Footnotes (1)
  • [F1]Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of March 6, 2022, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date.

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1
  • filerCIK 0001699684

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 8:00 PM ET
Size
5.4 KB